OBJECTIVES: Sequence analysis of known antibiotic resistance genes of the Mycobacterium tuberculosis complex (MTBC) is increasingly being used to infer phenotypic resistance to a variety of antibiotics. However, a clear understanding of the genotype-phenotype relationship is required to interpret genotypic susceptibility results accurately. In this context, it is particularly important to distinguish phylogenetically informative neutral polymorphisms from true resistance-conferring mutations. METHODS: Using a collection of 71 strains that encompasses all major MTBC genotypes, we mapped the genetic diversity in 18 genes that are known to be involved or were previously implicated in antibiotic resistance to eight current as well as two novel antibiotics. This included bedaquiline, capreomycin, ethambutol, fluoroquinolones, isoniazid, PA-824, para-aminosalicylic acid, prothionamide, rifampicin and streptomycin. Moreover, we included data from one of our prior studies that focused on two of the three known pyrazinamide resistance genes. RESULTS: We found 58 phylogenetic polymorphisms that were markers for the genotypes M. tuberculosis Beijing, Haarlem, Latin American-Mediterranean (LAM), East African Indian (EAI), Delhi/Central Asian (CAS), Ghana, Turkey (Tur), Uganda I and II, Ural and X-type, as well as for Mycobacterium africanum genotypes West African I (WA I) and II (WA II), Mycobacterium bovis, Mycobacterium caprae, Mycobacterium pinnipedii, Mycobacterium microti and Mycobacterium canettii. CONCLUSIONS: This study represents one of the most extensive overviews of phylogenetically informative polymorphisms in known resistance genes to date, and will serve as a resource for the design and interpretation of genotypic susceptibility assays.
OBJECTIVES: Sequence analysis of known antibiotic resistance genes of the Mycobacterium tuberculosis complex (MTBC) is increasingly being used to infer phenotypic resistance to a variety of antibiotics. However, a clear understanding of the genotype-phenotype relationship is required to interpret genotypic susceptibility results accurately. In this context, it is particularly important to distinguish phylogenetically informative neutral polymorphisms from true resistance-conferring mutations. METHODS: Using a collection of 71 strains that encompasses all major MTBC genotypes, we mapped the genetic diversity in 18 genes that are known to be involved or were previously implicated in antibiotic resistance to eight current as well as two novel antibiotics. This included bedaquiline, capreomycin, ethambutol, fluoroquinolones, isoniazid, PA-824, para-aminosalicylic acid, prothionamide, rifampicin and streptomycin. Moreover, we included data from one of our prior studies that focused on two of the three known pyrazinamide resistance genes. RESULTS: We found 58 phylogenetic polymorphisms that were markers for the genotypes M. tuberculosis Beijing, Haarlem, Latin American-Mediterranean (LAM), East African Indian (EAI), Delhi/Central Asian (CAS), Ghana, Turkey (Tur), Uganda I and II, Ural and X-type, as well as for Mycobacterium africanum genotypes West African I (WA I) and II (WA II), Mycobacterium bovis, Mycobacterium caprae, Mycobacterium pinnipedii, Mycobacterium microti and Mycobacterium canettii. CONCLUSIONS: This study represents one of the most extensive overviews of phylogenetically informative polymorphisms in known resistance genes to date, and will serve as a resource for the design and interpretation of genotypic susceptibility assays.
Entities:
Keywords:
bedaquiline; sequence analysis; single nucleotide polymorphisms
Authors: Maha R Farhat; Razvan Sultana; Oleg Iartchouk; Sam Bozeman; James Galagan; Peter Sisk; Christian Stolte; Hanna Nebenzahl-Guimaraes; Karen Jacobson; Alexander Sloutsky; Devinder Kaur; James Posey; Barry N Kreiswirth; Natalia Kurepina; Leen Rigouts; Elizabeth M Streicher; Tommie C Victor; Robin M Warren; Dick van Soolingen; Megan Murray Journal: Am J Respir Crit Care Med Date: 2016-09-01 Impact factor: 21.405
Authors: Silke Feuerriegel; Viola Schleusener; Patrick Beckert; Thomas A Kohl; Paolo Miotto; Daniela M Cirillo; Andrea M Cabibbe; Stefan Niemann; Kurt Fellenberg Journal: J Clin Microbiol Date: 2015-04-08 Impact factor: 5.948
Authors: Joseph Shea; Tanya A Halse; Pascal Lapierre; Matthew Shudt; Donna Kohlerschmidt; Patrick Van Roey; Ronald Limberger; Jill Taylor; Vincent Escuyer; Kimberlee A Musser Journal: J Clin Microbiol Date: 2017-04-05 Impact factor: 5.948
Authors: Laura E Via; Rada Savic; Danielle M Weiner; Matthew D Zimmerman; Brendan Prideaux; Scott M Irwin; Eddie Lyon; Paul O'Brien; Pooja Gopal; Seokyong Eum; Myungsun Lee; Jean-Philippe Lanoix; Noton K Dutta; TaeSun Shim; Jeong Su Cho; Wooshik Kim; Petros C Karakousis; Anne Lenaerts; Eric Nuermberger; Clifton E Barry; Véronique Dartois Journal: ACS Infect Dis Date: 2015-05-08 Impact factor: 5.084
Authors: Julius Brandenburg; Jan Heyckendorf; Franziska Marwitz; Nicole Zehethofer; Lara Linnemann; Nicolas Gisch; Hande Karaköse; Maja Reimann; Katharina Kranzer; Barbara Kalsdorf; Patricia Sanchez-Carballo; Michael Weinkauf; Verena Scholz; Sven Malm; Susanne Homolka; Karoline I Gaede; Christian Herzmann; Ulrich E Schaible; Christoph Hölscher; Norbert Reiling; Dominik Schwudke Journal: ACS Infect Dis Date: 2022-06-28 Impact factor: 5.578
Authors: Maha R Farhat; Karen R Jacobson; Molly F Franke; Devinder Kaur; Alex Sloutsky; Carole D Mitnick; Megan Murray Journal: J Clin Microbiol Date: 2016-01-13 Impact factor: 5.948
Authors: Francesc Coll; Ruth McNerney; Mark D Preston; José Afonso Guerra-Assunção; Andrew Warry; Grant Hill-Cawthorne; Kim Mallard; Mridul Nair; Anabela Miranda; Adriana Alves; João Perdigão; Miguel Viveiros; Isabel Portugal; Zahra Hasan; Rumina Hasan; Judith R Glynn; Nigel Martin; Arnab Pain; Taane G Clark Journal: Genome Med Date: 2015-05-27 Impact factor: 11.117